42 Comments

Tragic.

Beyond mRNA injections, please don’t be so quick to let the DNA ones (e.g., AstraZenica and J&J) off the hook. They also encode the Covid spike protein.

Expand full comment

The evidence against the ""shot" is becoming more and more overwhelming as each hour passes.

Expand full comment

25, 20 and 22 year old females dying of heart attacks etc is not normal.

Expand full comment

I dunno…I’m not a swami or doctor or anything but I’d swear the people in these pictures don’t look like the type that just keel over and die. But what do I know? Fauci’s the expert, right? Maybe he should explain it.

Expand full comment

Most likely global warming. Possibly solar flares. Outside shot at high tides.

Expand full comment

As Uncle Joe Brandon would say, it's due to the Crimate Clisis.

Expand full comment

I will pray for these lost souls.They just didn't do their critical research and realise it was a PlanDEMIC

Expand full comment

I haven’t updated this for a bit, but back then when I posted it there were 150 Canadian doctors who had died post-YouKnowWhat:

tinyurl.com/MustSeeCanadianDoctors

Expand full comment

Dead doctors. Three years ago I would have wept for their souls...

Today I cannot wipe the shit-eating grin from my face.

Expand full comment

Yes, yes and yes!

Expand full comment

LÜBECK IMMUNISATION AGAINST CORONA

February 25, 2021

In the past, an extremely powerful research & development division was built up in the Company Euroimmun under my direction, which is also involved in the diagnostics of infectious diseases. Our scientists were among the first to develop reagents for the identification of a whole range of newly emerging infections, often in close cooperation with specialists from international research institutes for infectious diseases, for instance in Germany the Bernhard-Nocht Institute (Hamburg) and the Robert-Koch Institute (Berlin): Crimean Congo, West Nile, Japanese encephalitis, usutu, dengue, chikungunya, mayaro, MERS corona, zika, SARS 1, ebola.

Based on the extensive experience in the development of reagents used for the diagnostics of viral infections, we created and produced, in a fast and targeted manner, a recombinant antigen construct for reliable detection of antibodies against SARS-CoV-2. The construct is based on a receptor-binding domain (RBD, Arg319-Phe541) in the S1 subunit of the spike protein used by the virus to bind to receptors of the target cells. It was pretty clear for me that vaccination with this protein would provide protection from in the infection.

Some vaccinations have a large and some a very low risk potential. It makes a difference whether a healthy human being is injected with an attenuated virus or virus RNA or with a tiny inconspicuous recombinant protein that cannot cause much harm in the organism, except for specifically stimulating the immune system. For decades, recombinant antigens genetically engineered in culture cells have been used for vaccination against infectious hepatitis A and B. In earlier times, the vaccination antigen had been extracted from blood collected from persons with past hepatitis; the recombinant antigens, however, are artificially designed, easy to produce and do not harbour any infection risk – a great step forward. I myself have vaccinated thousands of my employees with this kind of vaccines. However, it is important to perform three injections in the first quarter and to determine the antibody titre every five to ten years, followed by a booster, if necessary.

This uncomplicated vaccination scheme, which has proven itself over decades and uses a readily available trivial antigen, would have been the order of the day in the case of Covid-19. To adopt completely new approaches, for instance, of introducing virus RNA into the body of vaccinees whose organisms first have to synthesise the vaccination antigen, may be effective but many people are scared because they fear that the virus RNA will take on a life of its own and cause unexpected harm their bodies. For this reason, lengthy vaccination studies had to be carried out, while the virus could spread like wildfire. Moreover, the vaccine is hard to produce, requires an unbroken cold chain from the manufacture to the application, many people have allergic reactions to the additive polyethylene glycol that is necessary for stabilisation and half of the vaccinated persons have to take sick leave after the second shot. Above all, however, the manufacturing requires years until the need is met and every single person is vaccinated. During this time, scientists are able to make their mark and patent owners can make very good money, while millions of humans are dying because they could not be vaccinated in time. “But woe to him who, hid from view, hath done the deed of murder base”! Who will follow hard upon his heels, I ask?

Similarly, coronaviruses produced in culture and inactivated thereafter are outdated as vaccination antigens in my opinion. With respect to hepatitis, they have long become obsolete. Why should they be used for corona? Similarly, nobody needs to be infected with vector viruses to introduce virus antigens into the body. I, for my part, use the ready-made, extracorporeally genetically engineered antigen, which carries virtually no risk. Until today, none of the one hundred persons I vaccinated in this way have become ill or had to take sick leave.

Some resistance has developed against my approach. People are unable or unwilling to recognise the great potential in the vaccination method that I suggested, although it is virtually risk-free, based on a dead vaccine, can be transported uncooled and stored in the fridge, does not introduce any scary genetic information of the virus into the body, does not contain an attenuated virus, does cause virtually no allergic reactions, and especially not against polyethylene glycol, can be administered in a doctor’s practice, is nearly risk-free and would therefore be much better accepted by the population. It can also be produced in large quantities, which makes it extremely suitable for mass vaccination. The first vaccination was rather trivial than heroic. There was no vector, no RNA, no inactivated coronavirus, but only a tiny peptide.

Take three times 15 microgrammes of recombinant RBD of the S1 subunit (Arg319-Phe541) for one person. As adjuvant I used alhydrogel from InvivoGen. Shake thoroughly and take up 200 microlitres of the mixture with a tuberculin syringe. Take up 10 millilitres of sodium chloride solution? with a larger syringe and add the 200 microlitres, mix well. Take 500 microlitres of the mixture per shot and mix with a portion of the antigen. Make sure everything is sterile.

With a single 2000-litres reactor, 35 g of antigen can be produced per day, which would suffice for 1 million persons. Using a high-density culturing system, five times as much can be yielded. Within half a year it would be possible to produce enough vaccine for 80% of the population in Germany in a medium-scale laboratory.

I have asked the Paul-Ehrlich Institute (PEI), which is the German Federal Institute for Vaccines and Biomedicines, for permission to carry out this simple vaccination as soon as possible with a larger number of volunteers to find out whether it would work as well as with me and my family and whether these volunteers would also remain free of secondary effects, including exposed persons. I

Expand full comment

My dentist went on a trip to Italy with his wife and died of a heart attack over there. He was 73 but he was also in the reserve national guard and an outdoorsman. He didn't want the vax but got it because of the reserves.

https://www.legacy.com/us/obituaries/sacbee/name/stephen-casagrande-obituary?id=38429931

Expand full comment

This is just another story of many that shows that the government/corporations can experiment on people and kill them to test their bio weapons, and do not care... Sometimes they tell beforehand, but most times they don't or they just LIE..

Target St Louis.. The Movie

After Hiroshima, the United States Army, eager for new ways to weaponize atomic power, engaged in a series of classified open air studies designed to test the effects of aerosol radiation in a metropolitan setting. At first the tests were described as defensive, the latest strategy against the threat of Russian bombers. But as later declassified documents suggest, the goal of the testing, (performed primarily in low-income and African-American neighborhoods of North St. Louis), was to develop offensive capabilities which could match the climate and terrain of downtown Moscow. Consequently, generations of St. Louis inhabitants were unwitting participants in a government testing program, which like the infamous Tuskegee Syphilis Project, was facilitated by the U.S. Department of Public Health. Target: St. Louis investigates the historical catalyst for these events, the survivor's quest for answers and the subsequent Federal legislation requiring informed consent by human subjects. The Target series aims to shed light on areas of structural inequality, specifically as it pertains to the African American experience. The reason for focusing on the African American experience exclusively, to "Target" these individual cities and events, is to clarify and contrast the inherent differences between what is held as the collective American immigrant perception of history with African American history, an inescapably alternative perspective on our nation as a whole that fundamentally questions the veracity of American exceptionalism.—Western Independent

Expand full comment